Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 32Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Voltaren

02 1Voltaren (Excluding Other Divisions)

03 6Voltaren/Cataflam

PharmaCompass

01

Brand Name : Voltaren/Cataflam

Diclofenac

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Voltaren/Cataflam

arrow
2024 ACI Convention
Not Confirmed

Diclofenac

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 360

2019 Revenue in Millions : 417

Growth (%) : -14

blank

02

Brand Name : Voltaren/Cataflam

Diclofenac

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Voltaren/Cataflam

arrow
2024 ACI Convention
Not Confirmed

Diclofenac

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 373

2020 Revenue in Millions : 360

Growth (%) : 4

blank

03

Brand Name : Voltaren/Cataflam

Diclofenac

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Voltaren/Cataflam

arrow
2024 ACI Convention
Not Confirmed

Diclofenac

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 334

2021 Revenue in Millions : 373

Growth (%) : -10

blank

04

Brand Name : Voltaren

Diclofenac

arrow
2024 ACI Convention
Not Confirmed

05

Brand Name : Voltaren

Diclofenac

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Voltaren

arrow
2024 ACI Convention
Not Confirmed

Diclofenac

Main Therapeutic Indication : Others

Currency : USD

2015 Revenue in Millions : 632

2014 Revenue in Millions : 558

Growth (%) : -12%

blank

06

Brand Name : Voltaren (Excluding Other Divisions)

Diclofenac

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Voltaren (Excluding Other Divisions)

arrow
2024 ACI Convention
Not Confirmed

Diclofenac

Main Therapeutic Indication : Anti-Inflammatory

Currency : USD

2016 Revenue in Millions : 525

2015 Revenue in Millions : 558

Growth (%) : -6

blank

07

Brand Name : Voltaren/Cataflam

Diclofenac

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Voltaren/Cataflam

arrow
2024 ACI Convention
Not Confirmed

Diclofenac

Main Therapeutic Indication : Anti-inflammatory

Currency : USD

2017 Revenue in Millions : 465

2016 Revenue in Millions : 525

Growth (%) : -11

blank

08

Brand Name : Voltaren/Cataflam

Diclofenac

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Voltaren/Cataflam

arrow
2024 ACI Convention
Not Confirmed

Diclofenac

Main Therapeutic Indication : Anti-Inflammatory

Currency : USD

2018 Revenue in Millions : 445

2017 Revenue in Millions : 465

Growth (%) : -4%

blank

09

Brand Name : Voltaren/Cataflam

Diclofenac

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Voltaren/Cataflam

arrow
2024 ACI Convention
Not Confirmed

Diclofenac

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2019 Revenue in Millions : 417

2018 Revenue in Millions : 445

Growth (%) : -6

blank